2,712 STERIS plc $STE Shares Purchased by Valley National Advisers Inc.

Valley National Advisers Inc. grew its position in STERIS plc (NYSE:STE) by 34.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,691 shares of the medical equipment provider’s stock after purchasing an additional 2,712 shares during the period. Valley National Advisers Inc.’s holdings in STERIS were worth $2,245,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Corient Private Wealth LP boosted its stake in shares of STERIS by 109.7% during the 2nd quarter. Corient Private Wealth LP now owns 20,978 shares of the medical equipment provider’s stock worth $4,417,000 after buying an additional 10,976 shares during the last quarter. Kornitzer Capital Management Inc. KS acquired a new position in STERIS during the first quarter worth approximately $5,506,000. Strs Ohio increased its holdings in shares of STERIS by 9.5% during the 1st quarter. Strs Ohio now owns 71,748 shares of the medical equipment provider’s stock worth $15,866,000 after acquiring an additional 6,196 shares during the last quarter. Bessemer Group Inc. lifted its holdings in STERIS by 8.8% during the 1st quarter. Bessemer Group Inc. now owns 1,048,636 shares of the medical equipment provider’s stock valued at $231,883,000 after purchasing an additional 85,188 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd lifted its stake in shares of STERIS by 652.7% during the 1st quarter. Y Intercept Hong Kong Ltd now owns 7,286 shares of the medical equipment provider’s stock worth $1,611,000 after buying an additional 6,318 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on STE shares. Piper Sandler reissued an “overweight” rating and set a $275.00 price target (up from $270.00) on shares of STERIS in a report on Friday, August 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of STERIS in a report on Monday, August 24th. Wall Street Zen downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Sunday, October 11th. Finally, UBS Group dropped their price target on shares of STERIS from $275.00 to $270.00 and set a “buy” rating for the company in a research report on Friday, August 7th. Three analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, STERIS presently has a consensus rating of “Moderate Buy” and a consensus target price of $271.33.

STERIS Stock Up 0.0%

NYSE STE opened at $232.27 on Friday. The business has a fifty day moving average price of $220.09 and a two-hundred day moving average price of $218.16. The stock has a market capitalization of $22.65 billion, a PE ratio of 28.39 and a beta of 0.92. STERIS plc has a fifty-two week low of $195.14 and a fifty-two week high of $269.44. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.91 and a quick ratio of 1.35.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.49 by $0.10. STERIS had a return on equity of 14.34% and a net margin of 13.34%. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.49 billion. During the same quarter last year, the company posted $2.34 EPS. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. Equities analysts expect that STERIS plc will post 11.12 earnings per share for the current fiscal year.

STERIS Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Friday, September 4th were paid a $0.69 dividend. This represents a $2.76 annualized dividend and a yield of 1.2%. This is a boost from STERIS’s previous quarterly dividend of $0.63. The ex-dividend date of this dividend was Friday, September 4th. STERIS’s payout ratio is 33.74%.

Insiders Place Their Bets

In other STERIS news, Director Mohsen Sohi sold 4,058 shares of STERIS stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total value of $956,795.24. Following the transaction, the director owned 24,305 shares in the company, valued at $5,730,632.90. The trade was a 14.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.12% of the stock is owned by company insiders.

STERIS Company Profile

STERIS plc (NYSE: STE) provides products and services designed to support infection prevention, procedural care and the safe manufacture of healthcare and life sciences products. Its offerings include surgical equipment and operating-room solutions, sterilization and decontamination systems, endoscopy products, cleaning and disinfection technologies, and related consumable products.

The company also provides outsourced sterilization and laboratory services through its Applied Sterilization Technologies business.